Variable promoter methylation contributes to differential expression of key genes in human placenta-derived venous and arterial endothelial cells

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Joo, Jihoon E ^a   Hiden, Ursula ^b   Lassance, Luciana ^b   Gordon, Lavinia ^a   Martino, David J ^a   Desoye, Gernot ^b   Saffery, Richard ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

DNA methylation; Endothelial cells; Epigenetics; Gene expression; HPAEC; HPVEC; NOS3; Placenta; Reprogramming differentially methylated region

Indexed keywords

MICRORNA; NITRIC OXIDE SYNTHASE;

ARTERY ENDOTHELIUM; ARTICLE; CELL COMPONENT; CELL TYPE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC CODE; GENETIC REGULATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; NOS3 GENE; PLACENTA; VASCULAR ENDOTHELIUM;

ARTERIES; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; FEMALE; HUMANS; MICRORNAS; PLACENTA; PREGNANCY; PROMOTER REGIONS, GENETIC; TRANSCRIPTOME; VEINS;

EID: 84880124191     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-475     Document Type: Article

References (63)

1. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341(8850):938-941. 10.1016/0140-6736(93)91224-A, 8096277.
2. Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol 2001, 30(1):15-23. 10.1093/ije/30.1.15, 11171842.
3. Hanson M, Gluckman P. Endothelial dysfunction and cardiovascular disease: the role of predictive adaptive responses. Heart 2005, 91(7):864-866. 10.1136/hrt.2004.047381, 1769000, 15958346.
4. Aitsebaomo J, Portbury AL, Schisler JC, Patterson C. Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circ Res 2008, 103(9):929-939. 10.1161/CIRCRESAHA.108.184937, 2760069, 18948631.
5. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001, 128(19):3675-3683.
6. Torres-Vazquez J, Kamei M, Weinstein BM. Molecular distinction between arteries and veins. Cell Tissue Res 2003, 314(1):43-59. 10.1007/s00441-003-0771-8, 14505031.
7. Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009, 104(5):576-588. 10.1161/CIRCRESAHA.108.188805, 19286613.
8. Kume T. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 2010, 25(5):637-646. 2899674, 20238301.
9. Lang I, Schweizer A, Hiden U, Ghaffari-Tabrizi N, Hagendorfer G, Bilban M, Pabst MA, Korgun ET, Dohr G, Desoye G. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 2008, 76(10):1031-1043. 10.1111/j.1432-0436.2008.00302.x, 18673379.
10. Ho M, Yang E, Matcuk G, Deng D, Sampas N, Tsalenko A, Tabibiazar R, Zhang Y, Chen M, Talbi S, et al. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 2003, 13(3):249-262.
11. Fish JE, Marsden PA. Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium. Cell Mol Life Sci 2006, 63(2):144-162. 10.1007/s00018-005-5421-8, 16416260.
12. Matouk CC, Marsden PA. Epigenetic regulation of vascular endothelial gene expression. Circ Res 2008, 102(8):873-887. 10.1161/CIRCRESAHA.107.171025, 18436802.
13. Napoli C, Hayashi T, Cacciatore F, Casamassimi A, Casini C, Al-Omran M, Ignarro LJ. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis 2011, 215(1):9-22. 10.1016/j.atherosclerosis.2010.10.039, 21126740.
14. Bennett-Baker PE, Wilkowski J, Burke DT. Age-associated activation of epigenetically repressed genes in the mouse. Genetics 2003, 165(4):2055-2062. 1462878, 14704185.
15. Chan Y, Fish JE, D'Abreo C, Lin S, Robb GB, Teichert AM, Karantzoulis-Fegaras F, Keightley A, Steer BM, Marsden PA. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem 2004, 279(33):35087-35100. 10.1074/jbc.M405063200, 15180995.
16. Yan MS, Matouk CC, Marsden PA. Epigenetics of the vascular endothelium. J Appl Physiol 2010, 109(3):916-926. 10.1152/japplphysiol.00131.2010, 20413423.
17. Peng Y, Jahroudi N. The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem 2003, 278(10):8385-8394. 10.1074/jbc.M213156200, 12511565.
18. Wu J, Iwata F, Grass JA, Osborne CS, Elnitski L, Fraser P, Ohneda O, Yamamoto M, Bresnick EH. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol Cell Biol 2005, 25(4):1458-1474. 10.1128/MCB.25.4.1458-1474.2005, 548019, 15684396.
19. Johnson AB, Barton MC. Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat Res 2007, 618(1-2):149-162. 1924842, 17292925.
20. Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJ, Gavryushova A, Srivastava D, Marsden PA. Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 2010, 285(2):810-826. 10.1074/jbc.M109.067868, 2801283, 19880524.
21. Bronneke S, Bruckner B, Peters N, Bosch TC, Stab F, Wenck H, Hagemann S, Winnefeld M. DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells. Angiogenesis 2012, 15(2):317-329. 10.1007/s10456-012-9264-2, 22434260.
22. Palinski W. Maternal-fetal cholesterol transport in the placenta: good, bad, and target for modulation. Circ Res 2009, 104(5):569-571. 10.1161/CIRCRESAHA.109.194191, 19286612.
23. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res 2009, 104(5):600-608. 10.1161/CIRCRESAHA.108.185066, 19168441.
24. Scholler M, Wadsack C, Metso J, Chirackal Manavalan AP, Sreckovic I, Schweinzer C, Hiden U, Jauhiainen M, Desoye G, Panzenboeck U. Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL. J Clin Endocrinol Metab 2012, 97(7):2466-2474. 10.1210/jc.2011-2969, 22492872.
25. Novakovic B, Yuen RK, Gordon L, Penaherrera MS, Sharkey A, Moffett A, Craig JM, Robinson WP, Saffery R. Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics 2011, 12:529. 10.1186/1471-2164-12-529, 3216976, 22032438.
26. Martino D, Maksimovic J, Joo JH, Prescott SL, Saffery R. Genome-scale profiling reveals a subset of genes regulated by DNA methylation that program somatic T-cell phenotypes in humans. Genes Immun 2012, 13(5):388-398. 10.1038/gene.2012.7, 22495533.
27. Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Anwar SL, Kreipe HH, Lehmann U. Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina. Inc. BMC Res Notes 2012, 5(1):210.
28. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011, 98(4):288-295. 10.1016/j.ygeno.2011.07.007, 21839163.
29. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011, 3(6):771-784. 10.2217/epi.11.105, 22126295.
30. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997, 17(11):2479-2488. 10.1161/01.ATV.17.11.2479, 9409218.
31. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C, Marsden PA. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 2005, 280(26):24824-24838. 10.1074/jbc.M502115200, 15870070.
32. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999, 13(9):1055-1066. 10.1101/gad.13.9.1055, 10323857.
33. Edelstein LC, Pan A, Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. J Biol Chem 2005, 280(12):11192-11202. 10.1074/jbc.M412997200, 1382061, 15671023.
34. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J Biol Chem 1995, 270(46):27948-27953. 10.1074/jbc.270.46.27948, 7499271.
35. Eichmann A, Yuan L, Moyon D, Lenoble F, Pardanaud L, Breant C. Vascular development: from precursor cells to branched arterial and venous networks. Int J Dev Biol 2005, 49(2-3):259-267.
36. Jjingo D, Conley AB, Yi SV, Lunyak VV, Jordan IK. On the presence and role of human gene-body DNA methylation. Oncotarget 2012, 3(4):462-474. 3380580, 22577155.
37. Aran D, Toperoff G, Rosenberg M, Hellman A. Replication timing-related and gene body-specific methylation of active human genes. Hum Mol Genet 2011, 20(4):670-680. 10.1093/hmg/ddq513, 21112978.
38. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 2009, 27(4):361-368. 10.1038/nbt.1533, 3566772, 19329998.
39. Tsutsui M, Shimokawa H, Otsuji Y, Yanagihara N. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol Ther 2010, 128(3):499-508. 10.1016/j.pharmthera.2010.08.010, 20826180.
40. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001, 98(6):1904-1913. 10.1182/blood.V98.6.1904, 11535528.
41. Kim JY, Hwang JH, Zhou W, Shin J, Noh SM, Song IS, Kim JY, Lee SH, Kim J. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. Epigenetics 2009, 4(5):313-321. 10.4161/epi.4.5.9160, 19633424.
42. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 2001, 33(4):409-420. 10.1016/S1357-2725(01)00026-7, 11312109.
43. Ferrer FA, Miller LJ, Lindquist R, Kowalczyk P, Laudone VP, Albertsen PC, Kreutzer DL. Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology 1999, 54(3):567-572. 10.1016/S0090-4295(99)00156-9, 10475375.
44. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000, 60(2):203-212.
45. Quentmeier H, Eberth S, Romani J, Weich HA, Zaborski M, Drexler HG. DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). BMC Cancer 2012, 12:19. 10.1186/1471-2407-12-19, 3297533, 22251800.
46. Fitzner N, Clauberg S, Essmann F, Liebmann J, Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clinical and vaccine immunology: CVI 2008, 15(1):138-146. 10.1128/CVI.00257-07, 2223852, 17978010.
47. Diesel B, Ripoche N, Risch RT, Tierling S, Walter J, Kiemer AK. Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island. Innate Immun 2012, 18(1):112-123. 10.1177/1753425910394888, 21768203.
48. Wu F, Yang Z, Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 2009, 386(4):549-553. 10.1016/j.bbrc.2009.06.075, 2821898, 19540203.
49. Choi YC, Yoon S, Jeong Y, Yoon J, Baek K. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells 2011, 32(1):77-82. 10.1007/s10059-011-1042-2, 21544626.
50. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 2010, 107(30):13450-13455. 10.1073/pnas.1002120107, 2922125, 20624982.
51. Muramatsu F, Kidoya H, Naito H, Sakimoto S, Takakura N. MicroRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 2012, 32(4):414-421.
52. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
53. Lassance L, Miedl H, Konya V, Heinemann A, Ebner B, Hackl H, Desoye G, Hiden U. Differential response of arterial and venous endothelial cells to extracellular matrix is modulated by oxygen. Histochem Cell Biol 2012, Epub.
54. Novakovic B, Wong NC, Sibson M, Ng HK, Morley R, Manuelpillai U, Down T, Rakyan VK, Beck S, Hiendleder S, et al. DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta. J Biol Chem 2010, 285(13):9583-9593. 10.1074/jbc.M109.064956, 2843208, 20071334.
55. Gordon L, Joo JE, Powell JE, Ollikainen M, Novakovic B, Li X, Andronikos R, Cruickshank MN, Conneely KN, Smith AK, et al. Neonatal DNA methylation profile in human twins is specified by a complex interplay between intrauterine environmental and genetic factors, subject to tissue-specific influence. Genome Res 2012, 22(8):1395-1406. 10.1101/gr.136598.111, 3409253, 22800725.
56. Hansen KD, Aryee M. Minfi: Analyze Illumina's 450k methylation arrays. R package version 100
57. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset quantile Within-Array Normalization for Illumina Infinium Human Methylation450 BeadChips. Genome Biol 2012, 13(6):R44. 10.1186/gb-2012-13-6-r44, 3446316, 22703947.
58. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19(3):368-375. 10.1093/bioinformatics/btf877, 12584122.
59. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics (Oxford, England) 2008, 24(13):1547-1548.
60. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconducto. 2005, 397-420. New York: Springer, Gentleman R, Carey V, Dudoit S, Huber W, Irizarry R.
61. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.
62. Ollikainen M, Smith KR, Joo EJ, Ng HK, Andronikos R, Novakovic B, Abdul Aziz NK, Carlin JB, Morley R, Saffery R, et al. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet 2010, 19(21):4176-4188. 10.1093/hmg/ddq336, 20699328.
63. Wong NC, Novakovic B, Weinrich B, Dewi C, Andronikos R, Sibson M, Macrae F, Morley R, Pertile MD, Craig JM, et al. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett 2008, 268(1):56-62. 10.1016/j.canlet.2008.03.033, 18485586.